Sarah Blagden
banner
sarahblagden.bsky.social
Sarah Blagden
@sarahblagden.bsky.social
Professor of Cancer Research at Oxford University. Cancer Prevention, RNA biology, public engagement; eclectic leanings. Views my own.
Reposted by Sarah Blagden
The projected rise in global cancer deaths
1990 —5.9 million
2023—10.4 million
2050—18.8 million
is yet another reason we need to get primary prevention into high gear, which is now possible but not getting done
www.thelancet.com/journals/lan...
September 24, 2025 at 10:38 PM
Reposted by Sarah Blagden
Join our Prevention Primer on 24 June and grow your knowledge ahead of @cancerresearchuk.org's #PrevConf25. Hear from Prof Peter Sasieni, @sarahblagden.bsky.social, @wtklab.bsky.social and others, inc lab scientists, clinicians, behavioural scientists and epidemiologists.
bit.ly
April 14, 2025 at 9:30 AM
Following @eileenparkes.bsky.social lead, I asked ChatGPT to show me at work. Bang on. Uncanny
February 11, 2025 at 11:27 PM
Reposted by Sarah Blagden
Oxford and GSK launch £50million programme to advance novel cancer research oxfordbrc.nihr.ac.uk/oxford-and-g... Thanks to @sarahblagden.bsky.social & colleagues at @oxfordcancer.bsky.social Research Is Where Hope Starts
Oxford and GSK launch £50million programme to advance novel cancer research | NIHR Oxford Biomedical Research Centre
oxfordbrc.nihr.ac.uk
January 30, 2025 at 11:23 AM
Reposted by Sarah Blagden
@ox.ac.uk & GSK launch £50million immuno-prevention programme to advance novel cancer research

The programme, led by Prof. @sarahblagden.bsky.social of @oncology.ox.ac.uk, unites expertise from four departments across the University to explore the potential of cancer prevention through vaccination⬇️
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent ...
www.cancer.ox.ac.uk
January 27, 2025 at 10:22 AM
Should grant funding be randomly allocated? Yes, according to schemes funded by British Academy/Leverhulme and Wellcome IFRC. Luck versus Rigour?
a slot machine that says do n't gamble with lives on it
ALT: a slot machine that says do n't gamble with lives on it
media.tenor.com
November 28, 2024 at 9:15 AM
Reposted by Sarah Blagden
Ok first post on Bluesky and it’s a science one… New paper out from the lab! APOBEC genes protect us from viral infection but go rogue in cancer. Here we shed new light on how these important genes are regulated, offering clues as to what goes wrong in cancer.

www.embopress.org/doi/full/10....
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma | The EMBO Journal
imageimageAPOBEC3A and APOBEC3B encode DNA editing enzymes with anti-viral roles that generate somatic mutations in cancer. This study provides insight into their expression in healthy and cancerous e...
www.embopress.org
November 16, 2024 at 8:07 AM
Reposted by Sarah Blagden
📰BREAKING: The Man Van can diagnose #ProstateCancer in at-risk groups earlier and more affordably than the GP route.

Find out more about the research into the mobile health clinic, presented at #LGCW2024 ⤵️

www.icr.ac.uk/news-archive...
www.icr.ac.uk
November 16, 2024 at 12:03 AM
(…taps mike nervously)..well hello there Bluesky. Any scientists, oncologists or cancer biologists in the room?
November 16, 2024 at 9:21 AM